Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07579130 · ClinicalTrials.gov registry record
Comparative Assessment of Lipid Layer Thickness Measurements
A clinical trial, sponsored by Indiana University.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07579130: Recruiting study, sponsored by Indiana University.
NCT07579130 is a clinical trial that is actively recruiting participants, run by Indiana University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07579130 is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study compares ocular lipid layer thickness (LLT) measurements obtained from three commonly used clinical diagnostic devices to evaluate their agreement and consistency. It further examines which device's LLT measurements show the strongest correlation with established clinical indicators of dry eye disease severity.
Primary Outcome
Average and minimum lipid layer thickness measurements will be compared across devices
Interventions
- DEVICE LipiView
- DEVICE Omnicad
- DEVICE Bruder Ocular Surface Analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2028-12-20 |
What NCT07579130 shows while recruiting
NCT07579130 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which LipiView is the first listed.
NCT07579130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07579130 about?
NCT07579130 is a clinical study titled "Comparative Assessment of Lipid Layer Thickness Measurements". This study compares ocular lipid layer thickness (LLT) measurements obtained from three commonly used clinical diagnostic devices to evaluate their agreement and consistency. It further examines which device's LLT measurements show the strongest correlation with established clinical indicators of dr...
What is the current status of trial NCT07579130?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-04-01. Estimated completion is 2028-12-20.
What interventions are being tested in trial NCT07579130?
The interventions under investigation include: LipiView (DEVICE), Omnicad (DEVICE), Bruder Ocular Surface Analyzer (DEVICE).
Who is sponsoring clinical trial NCT07579130?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI